Press Releases
SAN DIEGO, Feb. 12, 2020 /PRNewswire/ -- Avidity Biosciences, Inc. (Avidity), a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today the appointment of Joseph Baroldi as Chief Operating Officer.
Read more...12 February 2020
BOTHELL, Wash., Feb, 12, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-clas
Read more...LINKÖPING, Sweden, Feb. 12, 2020 /PRNewswire/ -- The international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will publish its interim report for the period May to
Read more...12 February 2020
WOONSOCKET, R.I., Feb. 12, 2020 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced a series of leadership assignments to support the company's continued focus on innovation and strategic growth.
Read more...12 February 2020
FIBROSIS AND TISSUE REPAIR OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Feb. 12, 2020 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "C
Read more...12 February 2020
NEW YORK, Feb. 12, 2020 /PRNewswire/ -- Arie and Jennie Harel are expanding their Lice Troopers head lice removal business by opening four additional locatio
Read more...12 February 2020
LAKEWOOD, Colo., Feb. 12, 2020 /PRNewswire/ -- With a nearly 25% increase in the number of heart attacks on the Monday following Daylight Saving Time compared to the rest of the Mondays throughout the year1, Natural Grocers is on a mission to create a healthier America by ending Daylight Saving Time. On March 7, join Natural
Read more...12 February 2020
VANCOUVER, Feb. 12, 2020 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF) announced today that its Board of Directors has initiated a process to evaluate a range of strategic alternatives available to the Company (the "Strategic Review"). Mackie Research Capital Corporation and AltaCorp Capi
Read more...12 February 2020
LONDON, Feb. 12, 2020 /PRNewswire/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today commented on the issuance by the UK Competition and Markets Author
Read more...ATLANTA, Feb. 12, 2020 /PRNewswire/ -- Antios Therapeutics, Inc. ("Antios"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases, today announced it has initiated its first-in-human Phase I clinical trial for ATI-2173, a novel liver-targeted, orally-administered, small molecule against hepat
Read more...